 |
| | | Address
29 Nanxin St Flr 9
Xi'an
, Shaanxi Province 710004
Phone: 86.29.8727.1818
Website: http://www.chinapediatricpharma.com
| | Auditor |
|---|
Acquavella, Chiarelli, Shuster, Berkower & Co., LLP
| | Transfer Agent |
|---|
Transhare Corporation
| Employees: 192
ShareHolders: 419 | Founded: 2005
Domicile: Nevada | | | |
| | History: INCORPORATED in Nevada Apr. 20, 2005, as Belford Enterprises, Inc.; name changed to Lid Hair Studios International, Inc. Aug. 15, 2005, and to China Pediatric Pharmaceuticals, Inc. Oct. 9, 2009. On Sept. 30, 2009, the company acquired all of the outstanding capital stock of China Children Pharmaceuticals Co., Ltd. (China Children). In exchange for the equity interest in China Children, the company issued 7,000,000 (post-split) Common shares.
China Children was incorporated in Hong Kong on June 27, 2008. | | | | Subsidiaries: |
|---|
China Children Pharmaceuticals Co., Ltd.
Xi'an Coova Children Pharmaceuticals Co., Ltd.
| | | | | | | | | |
|
Management
|
|---|
| Officers | Position |
|---|
| Jun Xia | Chairman, President & Chief Executive Officer | | Minggang Xiao | Chief Financial Officer |
| | Directors |
|---|
| Wanxiang Li | | Nanjing Lin | | Jun Xia | | Minggang Xiao | | Xiaoying Zhang | | | |
| | | | Capitalization as of 12/31/2009: | | | | | Authorized Shares | Outstanding Shares |
|---|
| Common $0.001 par | 75,000,000 | 8,305,171 |
| | | | LONG TERM DEBT: None. | | | | Common $0.001 par | | | |
Stockholders:
03/30/2010,
419.
| | PRINCIPAL STOCKHOLDERS: March 30, 2010, Jun Xia owned or controlled 31.5% of the Common, Yangling Bodisen Biotech Development, Inc. 24.3%, IFG Investments Services, Inc. 12.6% and China National Information Network Trust 8.8%. | | | |
Transfer Agent: Transhare Corporation
Greenwood Village
, CO | | | | OTC Bulletin Board( Primary): CPDU | | | | Exchange | Year | High | Low |
|---|
| OTC Bulletin Board | 2009 | 6.1250 | 2.6250 |
|
| | | | RECENT DIVIDENDS: Common $0.001 par: No cash.
Common reverse split 2-for-7, ex-Dec. 14, 2009. | | | | | |
| | Annual Report |
|---|
| | | Income Statement | |
| 2009 | 2008 |
|---|
| Net sales | 16,738 | 14,669 | | Cost of sales | 6,999 | 5,084 | | Gross profit | 9,739 | 9,585 | | Selling, general and administrative expense | 6,515 | 6,544 | | Income from operations | 3,224 | 3,041 | | Interest income | - | 35 | | Other income | 3 | - | | Other expense | 72 | - | | Interest exp. | 22 | - | | Income tax | 617 | 484 | | Net income | 2,516 | 2,592 | | Share earns. basic | 0.31 | 0.31 | | Share earns. diluted | 0.29 | 0.31 |
| | | | Balance Sheet | |
| 2009 | 2008 |
|---|
| Assets: |
|
| | Cash & equiv. | 906 | 813 | | Accts. rec., net | 5,666 | 3,287 | | Other receivable | 43 | 42 | | Inventories | 886 | 544 | | Prepaid expenses | 4,243 | 2,935 | | Tot. curr assets | 11,744 | 7,621 | | Net property | 798 | 901 | | Goodwill | 613 | 613 | | Intangible Assets | 1,856 | 2,189 | | Total assets | 15,011 | 11,324 | | Liabilities: |
|
| | Short-term bank loan | 439 | 6 | | Accts. pay. | 254 | 451 | | Accrued expenses and other payables | 1,593 | 1,491 | | Taxes pay. | 516 | 361 | | Trade deposit received | 6 | - | | Tot. curr. liabs. | 2,808 | 2,309 | | Com. stk. p.$0.001 | 8 | 8 | | Paid-in cap. | 2,136 | 1,478 | | Retained earns. | 8,921 | 6,494 | | Statutory reserve | 812 | 722 | | Other comprehensive income | 329 | 313 | | Total liabs. | 15,011 | 11,324 |
| | | |
* China Pediatric Pharmaceuticals, Inc. was incorporated in the State of Nevada on April 20, 2005, under the name Belford Enterprises B.C. Ltd. and on August 15, 2005 changed its name to Lid Hair Studios International, Inc. On October 9, 2009, the company?s name was changed to China Pediatric Pharmaceuticals, Inc. On September 30, 2009, the Company entered into a Share Exchange Agreement with Eric Anderson and Asia-Pharm, pursuant to which the Company acquired all of the outstanding capital stock an ownership interest of China Children from Asia-Pharm. In exchange for the equity interest in China Children, the Company issued 2,000,000 (post-split) shares of common stock to the shareholders of Asia-Pharm. | | | |
| | Interim Report
|
|---|
| | | Data Not Available | | | | | | | | | |
| | Pro Forma Report
|
|---|
| | | Data Not Available | | | | | | | | | |
| | Quarterly Report Information
|
|---|
| | | Quarterly Revenue, US$ |
|---|
| Year | Quarter | Revenue | | 2010 |
1 | 6,710,000 | | 2009 |
1 | 3,600,000 | | 2009 |
2 | 3,550,000 | | 2009 |
3 | 4,180,000 | | 2009 |
4 | 5,420,000 | | 2009 |
Full Year
| 16,700,000 | | 2008 |
1 | 3,260,000 | | 2008 |
2 | 3,330,000 | | 2008 |
3 | 3,650,000 | | 2008 |
4 | 4,430,000 | | 2008 |
Full Year
| 14,670,000 | | 2007 |
Full Year
| 11,900,000 | | 2006 |
Full Year
| 3,460,000 |
| | | | | | Quarterly Net Income, US$ |
|---|
| Year | Quarter | Revenue | | 2010 |
1 | 1,470,000 | | 2009 |
4 | 330,000 | | 2009 |
Full Year
| 2,520,000 | | 2008 |
Full Year
| 2,590,000 | | 2007 |
Full Year
| 3,040,000 | | 2006 |
Full Year
| 800,000 |
| | | | | | Quarterly EPS, US$ |
|---|
| Year | Quarter | Revenue | | 2010 |
1 | .17 | | 2009 |
2 | .10 | | 2009 |
3 | .12 | | 2009 |
4 | .04 | | 2009 |
Full Year
| .29 | | 2008 |
2 | .07 | | 2008 |
4 | .14 |
| | | |
| |
|
